The U.S. Food and Drug Administration (FDA) has approved Filkri (filgrastim-laha), a biosimilar to Neupogen (filgrastim), to ...

Executive Chair Adam Craig said the company’s near-term focus is centered on advancing mavorixafor in chronic neutropenia, as ...

The findings, published in BJS Open by M. A. Zarog from the Department of Surgery and colleagues, suggest that circulating fibrocyte percentage (CFP) could help improve diagnostic accuracy in a ...

The FDA has accepted the new drug application (NDA) for tirabrutinib (ONO-4059), a highly selective, irreversible, second-generation Bruton tyrosine kinase (BTK) inhibitor developed for the treatment ...

The NDA is supported by data from part A of the phase 2 PROSPECT trial, which evaluated tirabrutinib in 48 adult patients with R/R PCNSL.

Higher baseline monocyte counts, along with preserved basophils and low C-reactive protein, independently predict complete remission on anti-IgE therapy for CSU.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the combination regimen of Venclexta® (venetoclax) ...

Nkosingiphile Gumede, already serving life sentences for the brutal murder of ANC councillor Sibusiso Maphumulo, has now been ...

First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY ...

Improivements across the board ...

South Africa's unemployment rate decreased to 31.4% in Q4 2025, with 44,000 new jobs. However, rising discouraged ...

Open letter to Comrade Gwede Mantashe. Dear Comrade Secretary General. When the ANC campaigned to be elected as the new ...